FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216092490> ?p ?o ?g. }

• W3216092490 endingPage "e2136014" @default.
• W3216092490 startingPage "e2136014" @default.
• W3216092490 abstract "The use of statins in patients with symptomatic peripheral artery disease remains suboptimal despite strong clinical practice guideline recommendations; however, it is unknown whether rates are associated with substantial improvements after lower extremity revascularization.To report longitudinal trends of statin use in patients with peripheral artery disease undergoing lower extremity revascularization and to identify the clinical and procedural characteristics associated with prescriptions for new statin therapy at discharge.This was a retrospective cross-sectional study using data from the Vascular Quality Initiative registry of patients who underwent lower extremity peripheral artery disease revascularization from January 1, 2014, through December 31, 2019. The Vascular Quality Initiative is a multicenter registry database including academic and community-based hospitals throughout the US. Patients aged 18 years or older undergoing lower extremity revascularization with available statin data (preprocedure and postprocedure) were included. Those not receiving statin therapy for medical reasons were excluded from final analyses.Patients undergoing lower extremity revascularization for whom statin therapy is indicated.Multivariate logistic regression was used to determine the clinical and procedural characteristics associated with new statin prescription for patients not already taking a statin preprocedure. The overall rates of statin prescription as well as rates of new statin prescription at discharge were determined. In addition, the clinical, demographic, and procedural characteristics associated with new statin prescription were analyzed.There were 172 025 procedures corresponding to 125 791 patients (mean [SD] age, 67.7 [11.0] years; 107 800 men [62.7%]; and 135 405 White [78.7%]) included in the analysis. Overall rates of statin prescription at discharge improved from 17 299 of 23 093 (75%) in 2014 to 29 804 of 34 231 (87%) in 2019. However, only 12 790 of 42 020 patients (30%) not already taking a statin at the time of revascularization during the study period were newly discharged with a statin medication. New statin prescription rates were substantially lower after endovascular intervention (7745 of 29 581 [26%]) than after lower extremity bypass (5045 of 12 439 [41%]). Body mass index of 30 or greater (odds ratio [OR], 1.13; 95% CI, 1.04-1.24; P < .001), diabetes (diet-controlled vs no diabetes, OR, 1.22; 95% CI, 1.05-1.41; P = .01), smoking (current vs never, OR, 1.32; 95% CI, 1.21-1.45; P < .001), hypertension (OR, 1.19; 95% CI, 1.09-1.29; P < .001), and coronary heart disease (OR, 1.26; 95% CI, 1.17-1.35; P < .001) were associated with an increased likelihood of new statin prescription after endovascular intervention, whereas female sex, older age, antiplatelet use, and prior peripheral revascularization were associated with a decreased likelihood.In this cross-sectional study, although statin use was associated with a substantial improvement after lower extremity revascularization, more than two-thirds of patients not already taking a statin preprocedure remained not taking a statin at discharge. Further investigations to understand the clinical implications of these findings and develop clinician- and system-based interventions are needed." @default.
• W3216092490 created "2021-12-06" @default.
• W3216092490 creator A5006119340 @default.
• W3216092490 creator A5020240170 @default.
• W3216092490 creator A5070180751 @default.
• W3216092490 creator A5074220226 @default.
• W3216092490 creator A5085163659 @default.
• W3216092490 date "2021-12-03" @default.
• W3216092490 modified "2023-10-15" @default.
• W3216092490 title "Prescribing of Statins After Lower Extremity Revascularization Procedures in the US" @default.
• W3216092490 cites W1965618515 @default.
• W3216092490 cites W1978878733 @default.
• W3216092490 cites W2018964531 @default.
• W3216092490 cites W2030475349 @default.
• W3216092490 cites W2037999818 @default.
• W3216092490 cites W2050318477 @default.
• W3216092490 cites W2055864845 @default.
• W3216092490 cites W2075347392 @default.
• W3216092490 cites W2082336558 @default.
• W3216092490 cites W2093023960 @default.
• W3216092490 cites W2093452916 @default.
• W3216092490 cites W2095075913 @default.
• W3216092490 cites W2096655546 @default.
• W3216092490 cites W2104734159 @default.
• W3216092490 cites W2133275623 @default.
• W3216092490 cites W2139148574 @default.
• W3216092490 cites W2148374679 @default.
• W3216092490 cites W2151793380 @default.
• W3216092490 cites W2160694670 @default.
• W3216092490 cites W2254048688 @default.
• W3216092490 cites W2318034339 @default.
• W3216092490 cites W2404680446 @default.
• W3216092490 cites W2616838800 @default.
• W3216092490 cites W2621718914 @default.
• W3216092490 cites W2783484560 @default.
• W3216092490 cites W2795246664 @default.
• W3216092490 cites W2805742915 @default.
• W3216092490 cites W2905331745 @default.
• W3216092490 cites W2914546434 @default.
• W3216092490 cites W2919920736 @default.
• W3216092490 cites W2931947540 @default.
• W3216092490 cites W2968097947 @default.
• W3216092490 cites W3008308972 @default.
• W3216092490 cites W3092282443 @default.
• W3216092490 cites W3101067241 @default.
• W3216092490 cites W3149508638 @default.
• W3216092490 cites W3183402545 @default.
• W3216092490 cites W4248820097 @default.
• W3216092490 cites W4254706444 @default.
• W3216092490 doi "https://doi.org/10.1001/jamanetworkopen.2021.36014" @default.
• W3216092490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34860245" @default.
• W3216092490 hasPublicationYear "2021" @default.
• W3216092490 type Work @default.
• W3216092490 sameAs 3216092490 @default.
• W3216092490 citedByCount "13" @default.
• W3216092490 countsByYear W32160924902021 @default.
• W3216092490 countsByYear W32160924902022 @default.
• W3216092490 countsByYear W32160924902023 @default.
• W3216092490 crossrefType "journal-article" @default.
• W3216092490 hasAuthorship W3216092490A5006119340 @default.
• W3216092490 hasAuthorship W3216092490A5020240170 @default.
• W3216092490 hasAuthorship W3216092490A5070180751 @default.
• W3216092490 hasAuthorship W3216092490A5074220226 @default.
• W3216092490 hasAuthorship W3216092490A5085163659 @default.
• W3216092490 hasBestOaLocation W32160924901 @default.
• W3216092490 hasConcept C126322002 @default.
• W3216092490 hasConcept C141071460 @default.
• W3216092490 hasConcept C142724271 @default.
• W3216092490 hasConcept C151956035 @default.
• W3216092490 hasConcept C1862650 @default.
• W3216092490 hasConcept C194828623 @default.
• W3216092490 hasConcept C2426938 @default.
• W3216092490 hasConcept C2776839432 @default.
• W3216092490 hasConcept C2778959093 @default.
• W3216092490 hasConcept C2779134260 @default.
• W3216092490 hasConcept C2779464278 @default.
• W3216092490 hasConcept C2780182762 @default.
• W3216092490 hasConcept C500558357 @default.
• W3216092490 hasConcept C71924100 @default.
• W3216092490 hasConcept C98274493 @default.
• W3216092490 hasConceptScore W3216092490C126322002 @default.
• W3216092490 hasConceptScore W3216092490C141071460 @default.
• W3216092490 hasConceptScore W3216092490C142724271 @default.
• W3216092490 hasConceptScore W3216092490C151956035 @default.
• W3216092490 hasConceptScore W3216092490C1862650 @default.
• W3216092490 hasConceptScore W3216092490C194828623 @default.
• W3216092490 hasConceptScore W3216092490C2426938 @default.
• W3216092490 hasConceptScore W3216092490C2776839432 @default.
• W3216092490 hasConceptScore W3216092490C2778959093 @default.
• W3216092490 hasConceptScore W3216092490C2779134260 @default.
• W3216092490 hasConceptScore W3216092490C2779464278 @default.
• W3216092490 hasConceptScore W3216092490C2780182762 @default.
• W3216092490 hasConceptScore W3216092490C500558357 @default.
• W3216092490 hasConceptScore W3216092490C71924100 @default.
• W3216092490 hasConceptScore W3216092490C98274493 @default.
• W3216092490 hasIssue "12" @default.
• W3216092490 hasLocation W32160924901 @default.
• W3216092490 hasLocation W32160924902 @default.

• next